Lymphoma & Plasma Cell Disorders
Conference Coverage
Group calls for more investment in radiotherapy
woman for radiotherapy Photo by Rhoda Baer VIENNA—Millions of people throughout the world are dying from potentially treatable cancers because of...
Conference Coverage
CLL: No symptoms, no treatment still appropriate
Despite exciting new advances in the understanding of chronic lymphocytic leukemia, particularly with respect to prognostic features that predict...
Conference Coverage
Nonviral gene transfer of CARs tested in humans
Photo courtesy of MDACC NEW YORK—Researchers have used a nonviral approach to create chimeric antigen receptor (CAR) T cells and tested these...
Conference Coverage
Problems in pediatric cancer care in Europe
Photo by Logan Tuttle VIENNA—Despite progress made in recent years, there are “major problems” in pediatric oncology care in Europe, according to...
News
Data support subcutaneous bortezomib in multiple myeloma
Subcutaneous and intravenous bortezomib performed comparably well in patients with newly diagnosed multiple myeloma, with a trend toward higher...
Conference Coverage
Pregnant cancer patients: Start treatment ASAP
Photo by Nina Matthews VIENNA—Women who are pregnant when diagnosed with cancer should carry their child to term but start cancer treatment...
Conference Coverage
Variations in blood cancer survival across Europe
chemotherapy Photo by Rhoda Baer VIENNA—Results of the EUROCARE-5 study have revealed regional differences in survival for European patients with...
News
NICE backs discounted idelalisib for CLL
The UK’s National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending that the PI3Kδ inhibitor...
News
Childhood cancer increases material hardship
Photo by Bill Branson Results of a small study reveal the material hardships families experience when a child is undergoing cancer treatment....
News
Reducing side effects of CAR T-cell therapy
Photo courtesy of UCSF Researchers have reported progress in developing an “on/off switch” to temper the over-active immune response and severe...
News
Topical resiquimod effective for early-stage cutaneous T-cell lymphoma
Key clinical point: Topical resiquimod was effective and well tolerated in patients with early-stage cutaneous T-cell lymphoma (CTCL).